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The requirement for a group of normal serum factors, collectively designated 
as complement, for injury or destruction of cells sensitized with antibody has 
been recognized for more than 70 years (1). The participation of complement 
in  immune  destruction  of  erythrocytes  (immune  hemolysis)  has  been  most 
intensively  studied,  primarily  because  of  technical  feasibility.  Considerable 
attention has also been given to the destruction of Gram-negative bacteria by 
antibody and complement (immune bacteriolysis). Although some evidence is 
available  that normal  serum factors resembling  complement also participate 
with antibody in the killing of mammalian cells other than erythrocytes (im- 
mune cytotoxicity) (2-13), this activity of complement has been least dearly 
defined, 
Investigation of the phenomenon of immune cytotoxicity is of fundamental 
biological  interest  from  the  standpoints  of  general  mechanisms  of  cellular 
injury and of specific mechanisms of tissue damage in hypersensitivity states. 
Although an ultimate aim of such investigation is elucidation of mechanisms 
of  immune  injury  of  human  cells  in  ~ivo,  it  appeared  desirable  initially  to 
establish  in  vitro  a  model system in  which factor requirements and reaction 
sequences could be studied with greater facility. 
The model system consisted of freshly isolated normal human amnion cells, 
rabbit  anti-human  amnion antibody and normal human  serum.  The amnion 
cell  was  selected because  of  the  desire  to  establish  the  model  with  normal 
fixed-tissue  cells  of  human  origin,  the  ready  availability  of  sterile  human 
placentas and the relative ease with which suspensions of amnion cells could 
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be prepared from them. The humoral constituents of the system were also of 
human origin when this was possible.  For this reason, normal human serum 
was  used almost exclusively as  the  source  of  normal serum factors  required 
for immune cytotoxicity and exclusively as a source of growth-promoting factors 
in tissue culture media. Recourse to  a  heterologous reagent was necessary in 
the case of anti-human amnion antibody; for  convenience, this  was  prepared 
in the rabbit. 
Two criteria of cytotoxicity were employed in this investigation: (a) metabo- 
lism-inhibition, measuring the  diminished production of  metabolic acids  by 
injured cells (7, 14) ; and (b) uptake of trypan blue, measuring the loss of ability 
of injured cells to exclude this acid dye (2, 15). The results of the experiments 
to  be  described  demonstrated  that  antibody,  the  components of  hemolytic 
complement and calcium and magnesium ions were all  required  for  immune 
cytotoxic  effects  on  human  amnion cells.  An  initial separation  of  reaction 
stages in this system is presented in the following paper (16). 
Materials and Methods 
Human Serum.--Human  blood collected without  anticoagulant  was allowed to  clot at 
room temperature for 1 to 3 hours and was stored at 1  ° overnight for maximal clot retraction. 
The serum was separated by centrifugation at 1  °. Pools of serum from 10 to 25 donors were 
employed in most experiments. 
Guinea Pig Serum.--Guinea pig blood was drawn either by cardiac puncture or exsanguina- 
tion from the carotid artery and the serum separated as  described for  human serum. Ly- 
ophilized and freshly reconstituted guinea pig serum (Carworth Farms, New City, New York) 
was used equally satisfactorily in some experiments. 
Human Complement Reagents.--Complement  or fresh normal serum is designated C'. The 
components of complement are indicated by the symbols C'I, C'2, C'3, and C'4. Serum frac- 
tions or reagents which are deficient in C'I, C'2, C'3, or C'4 are designated R1, R2, R3, and 
R4, respectively. These reagents were employed for titration of components of complement 
and for determination of the requirement  for the various components of complement for im- 
mune cytotoxicity. It is recognized that C'3 has  been separated into two components (17) 
and that still another previously unrecognized serum  constituent may be required for com- 
plement function  (18). However, the operating definition of complement as a system with 
four components has been utilized in this investigation. 
R1 and R2 were prepared as routine by the method of dialysis (19, 20). In a few experi- 
ments, R1 was also prepared either by dilution (19) with subsequent lyophilization and re- 
constitution to 1.5 times the original serum volume with  barbital-Ca++-Mg++  buffer, or by 
incubation of serum with trisodium  ethylenediaminetetraacetate  (21). R2,  the  most labile 
of the serum reagents, was stabilized by suspension in either 0.3 u  sodium  chloride or pH 7.4 
barbital-Ca++-Mg  ++ buffer of ionic strength  0.30 and clarified by eentrifugation at 46,000 
G for 15 minutes. Mter sterile filtration (see below) and immediately prior to use, the reagent 
was adjusted to pH 7.4, if necessary, and diluted with sterile water to ionic strength 0.15 and 
a final dilution of 1/1.5 with respect to original serum. R3 was prepared by incubation of 
serum with zymosan (19, 22) and R4 by incubation of serum with either hydrazine or ammonia 
(19, 23). Because of the cytotoxic effect of hydrazine, R4 was prepared with ammonia for all 
experiments involving amnion cells. R4  prepared  with  either  ammonia or hydrazine was 
equally satisfactory for the titration of C'4 in the hemolytic system; the hydrazine reagent 
was used as routine. R1, R2, R3, and R4 were non-hemolytic in amounts used in the various A.  ROSS  AND  I.  H.  LEPOW  1087 
tests, were not anticomplementary, and recombined at test levels to  give 100 per cent hemol- 
ysis. 
Complement-fixed (CF) serum  (24), streptokinase-treated (SK) serum (25), and RP  (serum 
deficient in properdin)  (22)  were prepared according to published procedures. Heated serum 
was prepared by heating pooled normal human serum for 30 minutes at 56  ° . Serum heated 
for 30 minutes at 48  ° or 52  ° was used in some experiments but, unless otherwise indicated, 
the term heated serum refers to 56  ° . 
Complement-depleted serum, deficient in all four components of complement, was made by 
first incubating serum with zymosan to inactivate C'3,  then incubating with ammonia to 
inactivate C'4, and finally heating for 30 minutes at 56  ° to inactivate C'I and C'2. The result- 
ing reagent, free of detectable components of complement, was slightly anticomplementary. 
It was possible however to use this reagent with appropriate controls. 
Serum and serum reagents used in experiments on immune cytotoxicity were sterilized by 
filtration through Selas 01 and 015 or single 02 candle filters (Selas Corporation of America, 
Philadelphia)  or  Millipore  HA  filters  (MiUipore  Filter  Corp.,  Bedford,  Massachusetts). 
They were either maintained at 1  ° and used on the day of preparation or stored at --60  ° in 
a mechanical freezer. Serum and serum reagents were always tested after filtration and storage 
and were used only if they met the required criteria in the hemolytic system. 
Barbital Buffer (19,  22).--Barbital buffer at pH 7.4, ionic strength 0.15,  containing 1.5  X 
10-4x¢ Ca  ++ and 5 X  10-4M Mg  ++, was employed as diluent in hemolytic assays, unless other- 
wise  indicated. 
Sensitized  Sheep Erytkrocytes.--Sterile  sheep erythrocytes in Alsever's solution  (Cappell 
Laboratories, West Chester, Pennsylvania) were washed and sensitized with rabbit hemolysin 
(Certified Blood Donor Service, Inc., Jamaica, New York, or generously supplied by Dr. H. D. 
Piersma, Lederle Laboratories Division, American Cyanamid Co., Pearl River, New York), 
as described previously (22). 
Hemolytic Complement Assays.--Titrations of hemolytic complement and components of 
complement were performed according to  previously published methods  (19,  23,  24).  The 
50 per cent endpoint was employed for all component titrations and for determining the titer 
of complement-fixing antibody in antiserums using serial double-dilution techniques. Either 
the 50 per cent (C'H~) or 100 per cent (C'Hx00) endpoint was used for determining the hemo- 
lytic activity of serum or recombinations of serum reagents. The complement-equivalent of 
non-hemolytic serum reagents was based on the hemolytic activity (C'Hl00 units) of the normal 
human serum from which these reagents were prepared. 
Ethylenediaminetetraacetic Acid (EDTA).~The sodium,  magnesium, and calcium salts of 
EDTA (generously provided by Geigy Chemical Co., Ardsley, New York) were dissolved in 
distilled water and adjusted to pH 7.4 at a  final stock concentration of 0.15 u. 
Hanks' Balanced Salt Solution (BSS).--Stock solutions A and B (26), prepared with analytic 
reagent grade chemicals and water-soluble phenol red (Hartman-Leddon Co., Philadelphia), 
were filtered separately through 01 and 015 or single 02 candle filters and stored at 1  °. Prior 
to use, the stock solutions were mixed, diluted 10-fold  with distilled water, and brought to 
pH  7.6-7.8  with 1.4  per cent sodium bicarbonate previously autoclaved at 10 pounds per 
square inch for 10 minutes. A second sterile filtration was performed as above and antibiotics 
were then added:  100 units per ml. of crystalline penicillin potassium (Squibb), 100/zg. per 
ml.  of streptomycin base equivalent  (Lilly),  and  100 units per ml.  of mycostatin  (Squibb 
nystatin). 
Mixture  199.--The  10-fold  concentrate  without  sodium  bicarbonate  (Microbiological 
Associates, Inc., Bethesda, Maryland) was diluted 10-fold  with distilled water  and fortified 
if necessary with heated human serum or complement-depleted serum. The pH was adjusted 
to 7.6-7.8  with autoclaved  1.4 per cent sodium  bicarbonate and the solution sterilized by 
filtration through a  Millipore HA filter or through candle filters in the manner described for 1088  IMMUNE  CELLULAR  INJURY.  I 
BSS. Antibiotics were added exactly as for BSS and the mixture stored at 1  ° for use within 
3 to 4 weeks. 
Trypsin.--A 1 per cent aqueous solution of twice recrystallized trypsin containing approxi- 
mately 50 per cent MgSO4  (Worthington Biochemical Co., Freehold, New Jersey) was steri- 
lized by filtration through a Millipore HA filter, stored at 1  ° and used within 2 weeks. 
Human  Amnion CeUs.--The  procedure for obtaining amnion cells from human placentas 
was a modification of that described by Dunnebacke and Zitcer (27).  Placentas were obtained 
under  sterile  conditions from  the  Obstetrical  Services  of  University Hospitals  and  of  St. 
Luke's Hospital, Cleveland, primarily from deliveries by elective caesarian section. Vaginal 
deliveries yielded satisfactory placentas with lesser frequency. Immediately following delivery, 
the placenta was placed in a  sterile Pyrex pan covered with sterile aluminum foil.  Within 4 
hours of delivery, and usually within 1 hour, the umbilical cord was cut off, the placenta rinsed 
with sterile BSS, and the amnion stripped from the chorion and cut into several large pieces 
which were placed in successive washes of BSS until free of all visible blood. After washing, 
the amnion was either trypsinized immediately or stored at room temperature overnight in 
mixture 199 containing 20 per cent heated human serum and trypsinized the following day. 
If the amnion was to be trypsinized immediately, the pieces were placed in a  32 ounce pre- 
scription bottle containing 350 ml. of BSS, 40 ml. of 1 per cent trypsin was added gradually 
with constant agitation, and autoclaved 1.4 per cent sodium bicarbonate was then added to 
bring the pH to 7.7-7.8. The suspension was incubated in a water bath at 37  ° for 2.5 to 4 hours 
with manual shaking every 20 minutes.  Sodium bicarbonate was added as needed to main- 
tain the pH at 7.7-7.8. After incubation, the fluid containing the suspended amnion cells was 
passed through four layers of cotton gauze. The pieces of amnion withheld by the gauze were 
washed with 100 ml.  of mixture  199 containing 20 per cent heated human serum and the 
washings added to the original suspension. The pooled suspension was centrifuged at room 
temperature at 1000 r.p.m., (225 G) for 10 minutes, the superuatant discarded, and the residue 
resuspended to a volume of 25 ml. in mixture 199 containing 20 per cent heated human serum. 
This suspension was centrifuged at 500 r.p.m.  (45 G) for 5 minutes at room temperature and 
the superuatant discarded. The average yield from a  single placenta was 4.0 ml.  (1.5  to 5.3 
ml.) of packed cells.  Following resuspension to approximately 10 per cent by volume in mix- 
ture 199 containing either 10 per cent heated human serum or 10 per cent complement-de- 
pleted serum, microscopic examination revealed individual rounded cells of uniform appear- 
ance. The cell suspension was used immediately or stored at room temperature in stoppered 
tubes. The cells usually maintained viability, with several changes of medium, for at least 1 
week. 
If the amnion was not trypsinized on the day it was obtained, the washed pieces were 
stored overnight at room temperature in 100 ml. of mixture 199 containing 20 per cent heated 
human serum, transferred to BSS the next morning, and trypsinized as above. Both procedures 
provided equally satisfactory  cells  by the  criteria of  metabolic activity and  exclusion of 
trypan blue. 
All procedures were performed in an isolated room equipped with air filters. All media 
were  tested for sterility in thioglycollate broth or brain-heart infusion. Aseptic techniques 
were used in all manipulations involving the placenta or materials to be used in association 
with the amnion cells.  In short term experiments, in which trypan blue uptake was used as 
the indicator of cytotoxicity, only stock solutions were handled aseptically. 
Amn4on Antigen.--Amnion  cells,  for use as  antigen  in  the  preparation  of  rabbit  anti- 
human anmion serum, were obtained by the method outlined above except that after the 
initial centrifugation the cell pack was resuspended and washed at least 4  times in 0.15 
NaC1.  After each centrifugation, erythrocytes at the surface of the cell pack were removed 
with a capillary pipette. The washed cells, as free as possible of erythrocytes, were resuspended 
in 14 volumes of 0.15 M NaC1 and partially disrupted by successively freezing the suspension A.  ROSS  AND  I.  tI.  LEPOW  1089 
at  --60  ° and thawing at 37  ° a  total of 5  times.  The resulting suspension was divided into 
small aliquots and stored at  --20  ° until used. The antigen was stable for 2 to 4 months, as 
measured by its ability to participate in a  complement-fixation test with rabbit anti-human 
amuion serum. 
Rabbit Anti-Human Amnion Serum.--Male New  Zealand white rabbits weighing 3  to  4 
kg. were bled from a  marginal ear vein and injected in the contralaterai marginal ear vein 
with amnion antigen.  The  dose  and schedule of inoculation varied but good  results were 
obtained with 3 daily injections of 0.5 to 1.0 ml. followed by 4 days' rest for 3 successive weeks. 
Mter an additional 3 weeks of rest, a series of 3 daily injections was repeated. Six days after 
the last injection the rabbits were again bled from the ear and the serum separated. Additional 
antiserum was obtained by further booster injections and bleedings according to the same 
schedule.  Serums of suilicient potency on the basis of titer of complement-fixing antibody 
(see below) were pooled and frozen at  -60 ° after no treatment or at  --20  ° after either (a) 
heating for 30 minutes at 56  °,  (b) complement-depletion as described above, or (c) isolation 
of y,-globulin by the method of Nichol and Deutsch (28). 
Complement-Fixing (CF) Titers of Preparations of Rabbit Anti-Human Amnion Antibody.-- 
CF titers of heated or complement-depleted rabbit anti-human amnion serum and of rabbit 
anti-human amnion ~,2-globulin  were performed in  the following manner: 0.2  ml.  of  serial 
dilutions of the antibody preparation, 0.1 ml. of a  dilution of guinea pig serum containing 
2  C'H100 units, and 0.2 ml. of an optimal dilution of amnion antigen were incubated for 60 
minutes at 37°; 1.0 ml. of sensitized sheep erythrocytes was then added and the mixtures incu- 
bated further for 30 minutes at 37  ° .  Appropriate antigen,  antibody,  complement, and sen- 
sitized erythrocyte controls were always included. The CF titer was expressed as the greatest 
dilution of antibody which would permit 50 per cent hemolysis under test conditions. Treated 
antiserums were diluted, if necessary,  to  a  CF  titer  of  1/192.  The  preparation  of  anti- 
human smmion Tt-globulin had a CF titer of 1/384 and contained 4.8 mg. of nitrogen per ml. 
New batches of antibody were adjusted to the same CF titer as  previous  batches  by per- 
forming CF titers simultaneously on old and new preparations and by further reference to a 
standardized egg albumin-rabbit-anti-egg albumin system. 
Antigen for Adsorption Experiments.---Guinea pig  kidney  antigen was  prepared  by pub- 
lished methods  (29).  Human AB  erythrocytes were  obtained  from  defibrinated blood  and 
suspended in an equal volume of modified Alsever's solution (29). The cells were washed 3 
times with 0.15 ~  NaC1 prior to use. Sheep erythrocytes in Alsever's solution were treated in 
the same manner as human AB erythrocytes. Human amnion cells were prepared as described 
for immunization of rabbits and the insoluble residue used for adsorptions. 
Mineral (h'/.--Iieavy  mineral  oil  (drakeol No.  35,  Pennsylvania Refining  Co.,  Butler, 
Pennsylvania), for use in the metabolism-inhibition test, was autoclaved at  15 pounds per 
square inch for 15 minutes. 
Trypan Blue.--A 1 per cent suspension of  trypan blue (National Aniline Chemical  Co., 
New York) in 0.15 ~  NaC1 was clarified by low speed centrifugation for 5 minutes and stored 
in a brown bottle or shielded from direct light at all times. 
General.--Glassware used  in  cytotoxicity  experiments was  washed  with  calgon--sodium 
metasilieate  (30);  other  glassware  was  cleaned with sodium  dichromate-sulfuric acid.  All 
glassware was rinsed thoroughly with double distilled water. 
EXPER IM~.NTAL 
I. Metabolism Inhibition as a Criterion of Immune Cytotoxicity 
A.  General  Considerations.--A  modification  of  the  metabolism-inhibition 
technique of  Salk  and  Ward  (14)  was  used  as  one  criterion  of  immune  cyto- 
toxicity. The test is based on acid production by cells metabolizing in a  suitable 1090  IMMUNE  CELLULAR  INJURY.  I 
medium  containing  phenol  red  as  indicator.  The  amount  of  acid  produced, 
resulting  in a  decrease in pH  determined  colorimetrically with a  pH  compara- 
tor block containing phenol red standards,  is a  function of the number  of cells 
and their metabolic activity. Acid production  by a  given number  of cells may 
therefore be taken  as an index of cellular function and absence of acid produc- 
tion by the  same number  of cells as an index of cytotoxicity. 
A  major  purpose  of  this  investigation  was  to  determine  the  relationship  of 
hemolytic  complement  and  its  components  to  normal  human  serum  factors 
required  for  immune  cytotoxicity.  Accordingly,  it  was  necessary  to  exclude 
complement  from  the  supporting  medium  and  from  the  source  of  antibody 
and then to add known amounts in the form of human serum or serum reagents. 
For  many  experiments,  this  could  be  accomplished  by  using  mixture  199 
containing  10 per cent heated human  serum as supporting  medium and heated 
rabbit  anti-human  amnion  antiserum  as  antibody.  However,  since  heated 
serum  contains  small amounts  of  Ct3  and  relatively large  amounts  of  C'4,  it 
was mandatory  that  complement-depleted human  serum and rabbit antiserum 
be substituted  for the corresponding heated serums in all experiments designed 
to  test  the participation  of  C'3 and  C~4 in immune cytotoxicity.  On the other 
hand,  either  heated  or complement-depleted  serums  could be  used  with  com- 
parable  results  in  experiments  testing  the  participation  of  Cq  and  C'2  in 
immune cytotoxicity. 
B. Design of Experiments.--The  following constituents were added  aseptically to  sterile 
12 x 75 or 13 x 100 mm. test tubes: 
1.  0.05 ml. of heated or complement-depleted rabbit anti-human amnion antiserum having 
a CF titer of 1/192. 
2.  Various volumes of human  or guinea pig serum or human serum reagents,  diluted as 
required in mixture 199. 
3.  Mixture 199 to make a total volume at this step of 0.5 ml. 
4.  0.25 ml. of serial 2-fold dilutions of human amnion ceils suspended and diluted in mix- 
ture  199 containing either 10 per cent heated human serum or 10 per cent complement-de- 
pleted human serum. The original 10 per cent cell suspension  was initially diluted to a con- 
centration of 3.1 -4- 0.7 X  l0  T  cells per ml., as determined by hemocytometer count. Dilutions 
of this standardized suspension  were then made serially to 1/512. 
5.  0.5 m[ of mineral oil to exclude air-borne contamination. 
Controls lacking antibody,  serum or serum reagents,  or amnion ceils were included and 
the same volume of appropriate diluent was substituted. 
The tubes were incubated at 37 ° -4-. 0.5 ° for 5 days. The pH was determined daily to the 
nearest 0.2 pH unit by visual comparison with a pH comparator block containing phenol red 
standards.  The least dilution of ceils at which the pH after 5 days of incubation was equal 
to or greater than the initial pI-I was taken as the endpoint. Experimental and control series 
were performed at least in duplicate.  Two standard  deviations from the mean (95 per cent 
confidence  limits) was ±2-fold or one dilution of amnion cells for any single experiment. 
C. Definition of Cytotoxicity Index (C.L).--The cytotoxlcity index (C.I.) was  defined as the 
reciprocal of the least dilution of cells producing no acid with serum or serum reagent in the 
absence of antibody divided by the reciprocal of the least dilution of cells producing no acid 
with serum or serum reagent in the presence of antibody. For example, if with serum reagent A.  ROSS  AND  I.  H.  LEPOW  1091 
without antibody the least dilution of cells producing no acid was  1/256 while with serum 
reagent plus antibody the least dilution of cells producing no acid was 1/8, then the C.I. was 
256/8 or 32. Thus, in the presence of serum reagent and antibody in this example 32 times 
as many cells were required to produce the same metabolic effect as could be produced with 
serum reagent in the absence of antibody. Since the experimental error was +2-fold, a  C.I. 
of 0.5 to 2 was interpreted as absence of cytotoxicity and a C.I. of 4 or greater as an indicator 
of the presence of cytotoxicity. 
TABLE  I 
Requirement for Normal,  IIeat-Labile  Serum  Factors and  Antibody for  Cytotoxicity 
(Metabolism-Inhibition) 
Antiserum*  Normal senun~  C.I.§ 
1.  Fresh  None  16 
2.  Heated 
3.  ~ 
4.  ~ 
6.  None 
7.  ~ 
8.  ~c 
9.  None 
10.  " 
None 
Fresh guinea pig 
"  human 
Heated human 
Fresh rabbit 
"  guinea pig 
g~  human 
Heated rabbit +  fresh guinea pig 
"  "  +  fresh human 
1 
16 
16 
1 
1-2 
1-2 
1-2 
1-2 
1-2 
* Rabbit anti-human amnion antiserum; fresh =  unheated; heated  =  56  ° for 30 minutes; 
CF titer, 1/192. 
Guinea pig and human serums used at volumes equivalent to 10 C'Hl00 units of comple- 
ment; normal rabbit serum used at 0.05  ml. of undiluted serum to correspond to  amount 
of  antiserum  used;  fresh  --  unheated; heated  =  56  °  for  30  minutes. 
§ Calculated as  defined in text for lines 3  to 5; for lines 1 and 2  and 6  to 8  calculated 
on basis of metabolism of cells in indicated serums vs. metabolism in diluent alone; for lines 
9 and 10, calculated on basis of metabolism of cells in heated normal rabbit serum and fresh 
guinea pig or human serum  vs.  metabolism in  heated  normal rabbit serum. 
D.  Requirement  for  Normal,  Heat-Labile  Serum  Factors  and  Antibody.- 
Initial  experiments  were  designed  to  determine  qualitatively  whether  normal 
heat-labile  serum  factors  and  antibody  were  necessary  for  cytotoxicity.  The 
sources of  these factors were  normal  human  serum,  normal guinea pig serum, 
normal  rabbit  serum,  and  unheated  and  heated  rabbit  anti-human  amnion 
antiserum. The results, summarized in Table I, demonstrated  that metabolism- 
inhibition occurred  only  in  the  presence  of  both  antibody  and  normal,  heat- 
labile serum factors. Both antibody and normal serum factors were supplied by 
unheated  rabbit  anti-human  amnion  antiserum.  If the antiserum  was  heated, 
cytotoxicity was abolished but could be restored by fresh normal guinea pig or 
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following heating for 30 minutes at 56  ° or in the absence of antibody. These 
qualitative experiments therefore confirmed and extended previous observations 
(2-7, 9-13) and provided the basis for subsequent experiments on the nature of 
the normal, heat-labile, human serum factors required for immune cytotoxicity. 
E. Optimal  Concentrations of Normal Human Serum and Antibody.--Atten- 
tion was next directed toward determination of the optimal concentration of 
normal  serum  required  for  immune  cytotoxicity.  Human  serum  was  used 
exclusively for this  purpose  throughout the  remainder  of this  investigation. 
When antibody was  maintained  constant at 0.05  ml.  of heated rabbit  anti- 
human  amnion  antiserum  (CF  titer  =  1/192),  optimal  cytotoxicity was 
achieved at a  volume of normal human serum  (about 0.1  ml.)  equivalent to 
5 C~H100  units of complement. 
When  normal  human  serum  was  maintained  constant  at  5  CrH100 units, 
optimal cytotoxicity was  achieved at a  volttme of 0.05  ml.  of heated rabbit 
anti-human amnion antiserum (CF titer =  1/192). Since the concentration of 
amnion cells was  always varied as an integral part  of each test and in view 
of the preceding experiments, these conditions were used for subsequent studies. 
In separate experiments, it was found that adjustment of various batches of 
rabbit anti-human amnion antiserum to the same CF titer (1/192) resulted in 
uniform  cytotoxic indices  in  the  presence of a  constant  amount  of normal 
human  serum  and  with  the  same  preparation  of  amnion  cells.  Significant 
differences could not  be  detected among  the  cytotoxic activities  of various 
preparations of antibody (heated or complement-depleted rabbit anti-human 
amnion antiserums or the ~/~-globulin derived from the antiserum) when they 
were compared in a single experiment at the same CF titer in the presence of 
a constant amount of normal human serum. 
F.  Specificity  of  the  Antibody.--A  limited  investigation  was  made  of  the 
specificity of rabbit  anti-human  amnion  antiserum  with  respect to  reaction 
with human amnion cells,  major human blood group antigens, and Forssman 
antigen.  Heated  antiserum  was  adsorbed  at  0  °  for  60  minutes  with  equal 
volumes  of  amnion  antigen,  washed  sheep  erythrocytes,  or  washed  human 
erythrocytes (Type AB, Rh-positive) or with 5 volumes of 20 per cent suspen- 
sion of guinea pig  kidney. The  mixtures  were stirred  frequently  and  then 
centrifuged at 0 °.  The CF  titers and immune cytotoxic activities of the ad- 
sorbed and unadsorbed antiserums were compared, using amnion antigen and 
amnion  cell  suspensions  respectively  (Table  II).  Adsorption  with  amnion 
antigen  resulted  in  complete or  nearly  complete loss  of both  CF  titer  and 
immune cytotoxic activity. Adsorption with sheep or human erythrocytes or 
guinea pig kidney did not affect significantly either CF titer or immune cyto- 
toxic activity.  It  was  concluded  that  rabbit  anti-human  amnion  antiserum 
reacted, in both the CF test and metabolism-inhibition test, with an antigen 
of the amnion cell which was distinct from major human blood group antigens 
or Forssman antigen. Unadsorbed antiserum was therefore used as routine. A.  ROSS  AND  I.  H.  LEPOW  1093 
G.  Relation  of Normal  Human  Serum Factors to Hemolytic  Complement.- 
The preliminary experiments demonstrated  that  both  antibody and normal 
serum factors were required for  cytotoxicity by the criterion of metabolism- 
inhibition and that the activity of normal serum was abolished by heating for 
30 minutes at 56  °.  A  series of experiments was  then undertaken to compare 
the factors in normal human serum with hemolytic complement. 
1.  Beat-lability:  Aliquots  of human  serum  were heated for 30  minutes  at 
48  °, 52  °, and 56  ° and then tested for cytotoxic and hemolytic activities (Table 
TABLE  II 
Effect  of  Various  Adsorptions  on  CF  Titer  and  Immune  Cytotoxio Activity 
(Metabolism-Inhibition)  of Heated Rabbit Anti-Human Amnion 
• Antiserum 
Adsorbing agent 
None ............................................. 
Amnion antigen ................................... 
Human erythrocytes (AB, Rh-positive) .............. 
Sheep erythrocytes ................................ 
Guinea pig kidney* ................................ 
* Data  corrected  for dilution  of  antiserum with  gmnea 
TABLE  III 
CF tier  C.I. 
1:192  64 
1:8  2 
1:192  64 
1:192  64 
1:144  128 
pig  kidney  antigen. 
Effect  of Heat  on  Immune  Cytotowicity (Metabolism-Inhibition)  and Hemolyti#, Complement 
Activity of Human Serum 
Temperature  C.I.  Human serum 
*C. 
Unheated 
48 
52 
56 
64 
32 
2 
0.5 
C'Hloo unlts/ml 
42 
20 
0 
0 
III). At 48  °, residual cytotoxic activity was proportional to residual comple- 
ment  activity;  at  52  °  and  56  °,  both  cytotoxic and  hemolytic activities  of 
human serum were abolished. 
2.  Complement-fixation and treatment with streptokinase: Further similarities 
between cytotoxic and hemolytic complement activities of human serum were 
observed when normal human serum was incubated with either a  heterologous 
antigen-antibody  aggregate  formed  in  situ  or  a  solution  of  streptokinase 
(varidase,  Ledefle). Each  of these procedures destroyed all  or nearly all of 
both  the  cytotoxic and  hemolytic  activities  of  human  serum  (Table  IV). 
Neither  the  C.I.  nor  complement  activity  was  significantly  affected when 
serum was incubated with either antigen or antibody alone. 1094  IMMUNE  CELLULAR  INJURY.  I 
3.  Serum  reagents  deficient  in  individual  components  of complement:  R1,  R2, 
R3,  and  R4,  human  serum  reagents  deficient respectively in  Cq,  C'2,  CP3, 
and  CP4  and  conforming  to  previously  indicated  criteria  in  the  hemolytic 
system,  were  each  tested at  two  levels for  cytotoxic activity in  the presence 
of  the  standard  amount  of  rabbit  anti-human  amnion  antiserum.  The  anti- 
TABLE IV 
Effect  of  Complement-Fixation  and  Streptoklnase  Treatment  on  Immune  Cytotoxidty 
(Metabolism-Inhibition)  and  Hemolytic  Complement  Activity  of Human  Serum 
Treatment of h .....  erum  C.L 
L 
I 
! 
None ...........................  32 
Complement-fixation  ............  i  2 
Streptokinase-treatment  ...........  L  4 
I 
Human serum 
C'Htoo unils/ml. 
42 
0 
0 
Aliquots of human serum  incubated for 60 minutes at 37 ° with either 8 ~g. of purified 
pneumococcal  capsular polysaccharide,  Type  III and  200 #g.  of  rabbit  anti-S-III anti- 
body nitrogen per ml. of serum or with 1000 units of streptokinase (varidase,  Lederle)  per 
ml. of serum. 
TABLE V 
Immune  Cytotoxicity  (Metabolism-Inhibition)  of Human  Serum  and Serum  Reagents  at  Two 
Concentrations  of Hemolytic Complement 
Reagent 
Normal human serum ......... 
t 
R1 .........................  ! 
R2 .......................... 
R3 ........................ 
R4 .........................  I 
C.I. in presence of antibody  and 
5 C'H100 units of reagent  1 C'Hx00  unit of reagent 
Average 
48 
4 
2 
2 
2 
Range 
16-128 
2-8 
0.5-2 
Average  Range 
8  2-32 
2  0.5-8 
1  0.5-1 
1 
|  1-2 
serum was either heated or complement-depleted for experiments with R1  and 
R2; complement-depleted antiserum was used exclusively for experiments with 
R3 and R4. The data presented in Table V  represent a  summary of 11  experi- 
ments in which each reagent was tested a total of 3 to 11 times. Normal human 
serum from which the reagents were prepared was tested in each experiment. 
It will be noted that the cytotoxic activity of human  serum was greater at a 
higher  concentration  of  serum  but  that  cytotoxic activity at  either  level  of 
reagent was  diminished or entirely abolished when  any one of the 4  compon- 
ents of complement was not present. R2, R3, and R4 were consistently inactive A.  ROSS  AND  I.  H.  LEPOW  1095 
but  slight  residual  cytotoxicity was  usually  encountered  with  R1.  This  was 
observed not only when R1  was prepared by the dialysis procedure, as shown 
in Table V, but also when this reagent was prepared by the method of dilution 
or of incubation  with Na3EDTA.  The effect was also observed with R1  pre- 
pared by dialysis from 5  individual pools of human  serum which  were com- 
pared simultaneously. Definitive interpretation of these findings with R1  was 
not  possible,  although  it  may be  inferred  from data  in  the  following  paper 
that amounts of C~I which were not detectable by hemolytic assay were suffi- 
cient to cause significant cytotoxicity in the presence of C'2, C'3, and C'4. The 
experiments summarized in Table V  clearly suggested a  requirement  for the 
4 components of complement for immune cytotoxicity. 
TABLE VI 
Immune  Cytotoxicity  (Metabolism-lnhibiticn)  of Recombinations of Human  Serum  Reagents 
Compared with  Normal  Human  Serum  at  Equivalent  Levels of Hemolytic  Complement 
Reagent combination  C.I. of combination  C.I. of normal human serum at 
equivalent levels of C' 
R1 +  R2* 
R1 +  R3 
R1 +  R4 
R2 +  R3* 
R2 +  R4 
R3 +  R4 
24 
64 
8 
8 
16 
8 
8 
16 
16 
8 
16 
4 
* Each reagent recombined at the 5 unit  level; C.I. of starred  combinations and  their 
corresponding values for C.I. of normal human serum at equivalent concentrations of com- 
plement represent geometric average of 2 separate experiments; all other values represent 
single experiments for each combination and  an equivalent concentration of complement 
in the form of normal human serum. 
4.  Recombination  of  serum  reagents  deficient  in  individual  components  of 
complement:  Hemolytic complement activity of any one of the serum reagents 
R1,  R2,  R3,  and R4 may be restored by addition  of any of the 3  remaining 
reagents.  It was therefore of direct importance to compare the cytotoxic and 
hemolytic activities of the 6 possible recombinations of the 4  serum reagents 
in order to test further the relationship to hemolytic complement of the normal 
human serum factors required for immune cytotoxicity. 
The hemolytic activity of each recombination of serum reagents was deter- 
mined and found to vary between 20 and 67 per cent of the equivalent volume 
of normal human serum. The cytotoxicity of each of these recombinations with 
known hemolytic complement activity was then compared with the cytotoxicity 
of a volume of normal human serum equivalent to the same hemolytic comple- 
ment  activity.  The  results  (Table  VI)  showed  excellent  agreement  between 
C.I.  of  the  combinations  and  C.I.  of  human  serum  at  equivalent  levels  of 1096  IMMUNE  CELLULAR  INJURY.  I 
hemolytic complement for all recombinations except R1  +  R2 and R1  +  R3. 
Even with these recombinations, the discrepancies appeared to be within limits 
of experimental errors. 
5. Serum reagents deficient  in properdin: Human serum rendered deficient in 
properdin by a single adsorption with zymosan at 17 ° (RP) and highly deficient 
by a  second adsorption with zymosan at 37 °  (RPb)  (31) were compared in the 
metabolism-inhibition test with normal human  serum  at equivalent levels of 
hemolytic complement. The cytotoxic activities of RP and RPb were directly 
proportional  to  their  hemolytic  complement  activities.  It  was  concluded, 
therefore,  that  properdin  was  not  involved  in  immune  cytotoxicity  in  the 
system under investigation. 
II. Trypan Blue Uptake as a Criterion of Immune Cytotoxicity 
A.  General  Considerations.--The  investigations summarized  above  demon- 
strated that both antibody and normal serum factors were required for cyto- 
toxicity  by  the  criterion  of  metabolism-inhibition  and  indicated  positive 
correlations by a  variety of approaches between the properties of the normal 
serum factors and the components of hemolytic complement.  These observa- 
tions were tested by a  second criterion of cytotoxicity. The principle of exclu- 
sion of trypan blue by viable cells was adopted as a  rapid, technically simple 
indicator of cytotoxicity for this purpose. 
It was also desirable to devise a  test system for immune cytotoxicity which 
would be  more  readily susceptible to  separation of reaction stages  than  the 
metabolism-inhibition procedure.  The study described in the following paper 
was therefore anticipated in the design of these experiments. 
B. Design of Experiments.--In all of the experiments  to be described, amnion  cells were 
reacted with rabbit anti-human  amnion  "y2-globulin. The cells were  then  centrifuged  and 
washed in order to minimize the anti-complementary activity of the "y~-globulin.  On the basis 
of a series of preliminary experiments,  the following procedure was adopted. A suspension of 
tryps'mized human amnion cells in mixture 199 containing  10 per cent complement-depleted 
human serum was adjusted by dilution in this diluent to a concentration of 5.5 )< 105 cells/ 
ml. by hemocytometer  count. In a series of 12 x 75 mm. test tubes, 0.25 ml. of cell suspension 
and 0.25 ml. of a 1/20 dilution of rabbit anti-human amnion "y2-globulin  (CF titer undiluted 
=  1/384)  in mixture 199 were mixed and incubated for  10 minutes at room temperature 
(19-23°). The mixtures were centrifuged  for 5 minutes at 1000 r.p.m. (205 G) at room tem- 
perature, the supernatant fluids were decanted and discarded,  and the residues resuspended 
in 0.5 ml. of mixture 199 containing  10 per cent complement-depleted  human serum.  Cen- 
trifugation and  decantation were  repeated and  the  tubes containing the washed  residues 
were stoppered, kept at room  temperature, and used within a  7 hour period.  As shown in 
subsequent  tables, these antibody-coated cells were viable by the criterion of exclusion of 
trypan blue.  For controls, unsensitized  amnion cells were prepared by omission of antibody 
in the same experimental procedure. 
The amount of antibody used (60 #g. of ~/2-globulin  nitrogen)  represented  a  2.5 to 5-fold 
excess over the minimum  amount required to give optimal uptake of trypan blue by this 
number of amnion  cells after incubation for 30 minutes at 37  ° in the presence of 2 CrH100 
units of human serum.  The sensitization  of amnion  cells by rabbit anti-human amnion "Y2- A.  ROSS AND  I.  H.  L.EPOW  1097 
globulin was therefore performed according to the same principles employed for the sensitiza- 
tion of sheep erythrocytes by rabbit hemolysin for titrations of hemolytic complement. 
The immune cytotoxic activity of normal human serum and serum reagents was tested 
by appropriate dilution in mixture 199 so that the desired amount of reagent was contained 
in 0.5 ml. of solution. This volume was then added to the previously prepared washed residues 
of sensitized amnion cells.  The cells  were suspended by mixing and  the mixtures were in- 
cubated for 30 minutes at 37  °. Controls consisted of 0.5 ml. of the same dilutions of serum 
reagents in mixture 199 added to unsensitized amnion cells or of 0.5 ml. of mixture 199 con- 
TABLE VII 
Immune Cytotoxicity (Trypan Blue  Uptake)  of Human Serum and Serum Reagents  at Several 
Concentrations  of Hemolytic Complement 
Reagent 
Normal human serum ................... 
R1  ................................... 
R2  ................................... 
R.3 ................................... 
R4  ................................... 
RP ................................... 
Complement-fixed  serum ................ 
Streptokinase-treated serum ............. 
Serum heated for 30 min. at: 48 ° ......... 
,,  ,,  ,,  ,,  ,,  ,,  52 ° ......... 
,,  ,,  ,,  ,,  ,,  ,,  56  ° ......... 
Per  cent  stained  ceDs in  presence  of  indicated  C'H1oo 
units of human serumor semmreagents* 
None  0.8 unit 
21 
48 
24 
1 unit 
75 
90 
70 
2 units 
100 
7 
10 
8 
5 
7 
9 
4  units 
22 
23 
6 
6 
4 
5 
* For normal serum, for serum heated for 30 minutes at 48 °, and for RP, the indicated 
levels of complement were obtained by direct hemolytic titration; for all  other reagents, 
the indicated levels of complement were calculated on the basis of the hemolytic activity 
of the serum from which the reagent was prepared. 
taining 10 per cent complement-depleted human serum added to sensitized or unsensitized 
amnion cells. After incubation, 0.25 ml. of 1 per cent trypan blue was added, the tubes were 
shaken gently at room temperature for 2 minutes (32), an aliquot was placed in hemocytom- 
eter chambers, and the per cent of  stained  cells  was  determined at  once  by microscopic 
examination of at least 100 ceils under low power magnification (X 100). The start of incuba- 
tion of individual tubes was adjusted so that after incubation for 30 minutes sufficient time 
was available for staining and counting before the next sample was ready for staining. 
C.  Relation  of Normal  Human  Serum  Factors to  ttemolytic Complement.--A 
series of human  serum reagents, similar to those employed in the metabolism- 
inhibition test, was tested for cytotoxic activity on sensitized amnion cells by 
the  criterion of trypan  blue  uptake.  The  results  (Table  VII)  clearly demon- 1098  Im~LrNE  CELLULAR INJURY.  I 
strated that normal human serum was required for immune cytotoxicity, that 
inactivation of one or more of the components of complement by a  variety of 
TABLE VIII 
Immune  Cytotoxicity (Trypan  Blue  Uptake) of Recombinations of Human  Serum Reagents 
Compared with Normal Human  Serum at  Equivalent Levels of Hemolytic Complement 
Reagent combination* 
R1 +  R2 
R1 +  R3 
R1 +  R4 
R2 +  R3 
R2 +  R4 
R3 +  R4 
Actual hemolytic 
complement 
C*Hzoo units 
1.5 
0.56 
1.1 
1.1 
1.5 
0.78 
Per cent stained cells 
Observed 
92 
72 
93 
92 
96 
90 
Calculated 
97 
75 
96 
96 
97 
89 
* Each reagent recombined  at the 2 unit level. 
100 
8O 
60 
u-  1 
•  ~  40 
~  zo 
00  i  I  1  I 
0.50  1.0  1.5  L0 
C11"[ioo Units  of Human  Serum 
FIo. 1. Standard curve of hemolytic vs. cytotoxic activity of human serum  (trypan blue 
uptake); see Table VIII. 
procedures resulted in loss of cytotoxicity, and that properdin was not involved 
in the phenomenon. 
The 6  possible recombinations of R1,  R2,  R3,  and R4 were tested for both 
hemolytic and cytotoxic activities (Table VIII). A standard curve of hemolytic 
activity of  human  serum  vs.  immune  cytotoxicity was  established  (Fig.  1). A. ROSS AND I.  H.  LEPOW  1099 
The  hemolytic and  cytotoxic activities  of  each  reagent  recombination  were 
then experimentally determined.  In addition,  the expected cytotoxic activity 
of each recombination was calculated by reference to the standard curve. The 
observed and calculated values for cytotoxicity were in  excellent agreement, 
demonstrating a close correlation between the hemolytic and immune cytotoxic 
properties of human serum.  It will be noted that the values shown in  Fig.  1 
were different from those given in Table VII, possibly reflecting variations in 
the  sources  of cells or in  the  age of the  cell preparation.  For  this  reason,  a 
TABLE IX 
Comparison  of the effect of diluents on the cytotoxic  (trypan blue uptake) and hemolytic activities 
of human  serum in the presence  of various  salts  of EDTA 
Reagent 
Normal human serum 
None 
~¢ 
¢c 
Salt of EDTA 
1.5 X IO-2M 
Na 
Mg 
Ca 
Na 
Mg 
Ca 
Cytotoxic and hemolytic activities 
in indicated diluent 
Mixture  199 
Staine  cells  C'I-I6o  units 
~Ob~f C~t 
100  118 
9  0 
95  83 
92  154 
4 
3 
3 
5 
Barbital buffer* 
St  °  ~d  C'Hso units 
5  118 
6  0 
3  0 
7  125 
3 
6 
7 
8 
* Without added Ca  ++ and Mg++. 
standard  curve  was  obtained  simultaneously  with  the  performance  of  each 
experiment in order to minimize the effects of such variables. 
D. Requirement for Ca  H- and Mg  ++ for Immune  Cytotoxicity.--The  procedure 
of  measuring  cell  viability  by  trypan  blue  uptake  after  incubation  for  30 
minutes  permitted  investigation  of  the  requirement  for  Ca  ++  and  Mg  ++  in 
immune  cytotoxicity  (10).  Both  of  these  cations  are  required  for  immune 
hemolysis of sheep erythrocytes sensitized  with  rabbit antibody  (33)  and of 
human erythrocytes sensitized with human antibody from patients with par- 
oxysmal cold hemoglobinuria  (34).  However, modification of the  test system 
was required for this purpose. 
Human serum was diluted in mixture 199 in the presence of the sodium, magnesium, 
or  calcium salts of EDTA and  tested  for cytotoxic activity on  sensitized  amnion 
cells. The data  (Table IX) indicated a  requirement for Mg  ++ but not  Ca  ++ since 1100  CELLULAR IN~JRY.  I 
Na3 EDTA was inhibitory but Na~ Mg EDTA  and Na~ Ca EDTA were not.  The 
possibility was then considered that mixture  199  contained one or more substances 
which interfered with the chelation of Ca  ++ by Na, Mg EDTA. Such an interference 
effect has been noted under other circumstances (35).  Indeed, when  barbital buffer 
of pH 7.4, ionic strength 0.15 was substituted for mixture 199 as the diluent, a require- 
ment for Ca  ++ as well as Mg++ could be shown dearly. In this case, both Na3 EDTA 
and Na~ Mg EDTA inhibited cytotoxicity, but Na2 Ca EDTA did not (Table IX). 
None of these salts of EDTA was cytotoxic in control mixtures. The interfering effect 
of mixture 199 in demonstration of a  requirement for Ca++ could be also be demon- 
strated in immune hemolysis (Table IX). 
E. Irreversibility of Cytotoxicity.--Experiments  were performed to determine 
if  the  cytotoxic  effect  of  antibody,  complement  and  Ca++  and  Mg  ++  was 
reversible. 
Amnion cells sensitized with rabbit anti-human amnion ~,~-globulin  in the usual way were 
incubated at 37 ° for either 5 or 30 minutes in the presence of 2 C'H,00 units of fresh human 
serum  diluted in mixture  199. The cell complexes were  removed  by centrifugation for  5 
minutes at 500 R.P.~. (45 G), washed once with mixture 199 containing  10 per cent heated 
human serum, and suspended in the same diluent to the original cell concentration. Incuba- 
tion at 37 ° was then continued and aliquots were withdrawn for staining with trypan blue at 
intervals up  to  120  minutes.  No  reversibility of  cytotoxicity was  observed.  The  extent 
staining with trypan blue was 96 to 100 per cent regardless of the time of the initial incubation 
in the complete cytotoxic system or of subsequent incubation of the injured cells in supporting 
medium. 
III. Morphologic Alteration as a Criterion of Immune Cytotoxicity 
Attempts to  establish morphologic criteria for immune  cytotoxicity in  the 
experimental  model  employed  were  unsuccessful.  Trypsinized  amnion  cells 
were grown in monolayers in T  flasks and after a  confluent layer had formed, 
the desired serum reagents were added,  the flasks were incubated at 37 °  and 
the cells were observed microscopically for at least 60 minutes. In parallel with 
the  studies  on  metabolism-inhibition and on  trypan blue uptake,  aliquots of 
cells incubating in the presence of specific antibody and  serum  reagent  were 
sampled in duplicate at various times (0 to 68 hours)  and stained with either 
Papanicolaou  or  hematoxylin-eosin.  In  all  of  these  procedures,  there  was 
insufficient  difference  between  the  appearance  of  control  and  experimental 
cells  to  permit  conclusions  about  the  effect  of  antibody  and  normal  serum 
factors on  the morphology of human  amnion  cells. The  cellular lesion which 
was  reflected by  the  metabolism-inhibition test  and  by  increased  uptake  of 
trypan blue was therefore not associated with cytolysis or readily demonstrable 
morphologic alterations under these conditions. 
DISCUSSION 
The phenomenon of cytotoxicity and its production by humoral factors has 
long been of interest to investigators in the fields of immunology and experi- 
mental pathology. A variety of experimental models has been established using A. ROSS  AND  I. H.  LEPOW  1101 
cell types ranging from the chick embryo to human cells of malignant origin. 
In some of these systems, specific  antibody has been a  sole  requirement for 
cytotoxicity (36,  37);  in  others,  both  specific  antibody and  normal  serum 
constituents have been required (2-13, 38--40) ; and in still others, normal serum 
in the absence of demonstrable specific  antibody has sufficed (13, 37, 39-41). 
The present  investigation has been limited entirely to  in  vitro  experiments, 
utilizing primary isolates of a  normal, fixed-tissue cell  of human origin, the 
amnion cell.  Using  this  experimental model,  it  was found that  cytotoxicity 
depended on the presence of specific  rabbit  antibody, normal human serum 
factors which by a variety of criteria were indistinguishable from the compo- 
nents of hemolytic complement, and calcium and magnesium ions. The require- 
ments for immune cytotoxicity were therefore identical with those for immune 
hemolysis (33, 34). 
Evidence for the identity of the normal human serum factors required for 
immune cytotoxicity with the components of hemolytic complement rests on 
the following observations: 
1.  Requirement for specific antibody for cytotoxic and hemolytic activities 
of normal serum. 
2.  Partial loss of cytotoxicity to the same extent as loss of hemolytic activity 
when normal serum was heated for 30 minutes at 48°; complete loss of both 
cytotoxic and  hemolytic activities  when  normal  serum  was  heated  for  30 
minutes at 52 ° or 56 °  . 
3.  Inactivation of cytotoxic and hemolytic activities of normal serum by 
complement-fixation with antigen-antibody aggregates or by treatment with 
streptokinase. 
4.  Complete or nearly complete loss  of cytotoxic and hemolytic activities 
of normal serum in which a single component of complement had been inacti- 
vated (R1, R2, R3, and R4); restoration of cytotoxic and hemolytic activities 
of normal serum when any 2 of the 6 possible recombinations of R1, R2, R3, 
and R4 were tested. 
5.  Requirement for calcium and magnesium ions for cytotoxic and hemolytic 
activities of normal serum. 
In certain previous studies in which both antibody and normal serum  were 
required for cytotoxicity, identification of the normal serum constituents with 
complement was made primarily on the basis of heat-lability (56  °  , 30 minutes) 
(2-7,  9-13).  One report showed further that complement-fixed normal guinea 
pig serum, as well as heated normal guinea pig serum, was without cytotoxic 
activity on chick embryo hearts sensitized with specific  guinea pig antibody 
(42). In addition, Goldberg and Green (10) found that cytotoxic effects observed 
with specific rabbit ~,-globulin and normal rabbit serum could be abolished in 
the  presence  of  disodium  ethylenediaminetetraacetate and  restored  by  the 
addition of calcium and magnesium ions. These observations have been con- 1102  IMMUNE  CELLULAR  INJURY.  I 
firmed and  extended in  the  present  investigation with  human  amnion cells, 
rabbit antibody, and normal human serum. The results dearly support defini- 
tion of the normal human serum factors required for immune cytotoxicity as 
the components of hemolytic complement and calcium and magnesium ions. 
The model system described in this report had distinctly different normal 
serum requirements for immune cytotoxicity from that described by BjSrklund 
(38), using established lines of HeLa (originally derived from carcinoma of the 
human cervix), Detroit-6 (human marrow), heart, and conjunctival cells and 
specific partially  purified  antibody  produced  in  horses.  BjSrklund's  normal 
serum factor, obtained from either fresh human or horse serum, was inactivated 
by heat only at temperatures of 73  ° and greater. Its activity was not abolished 
by treating serum with either ammonia or zymosan or by isolation from the 
serum of a pseudo-globulin fraction with only Ct2 and CP4 activity. Further- 
more,  cytotoxicity was  not dependent on normal serum levels of calcium or 
magnesium ions. 
Two  differences between  BjSrklund's  experiments and  our  own are  to  be 
emphasized:  the  nature  of  the  cell  and  the  source of  the  antibody.  (a)  In 
BjSrklund's work, the antigen used for antibody production was prepared from 
human  tumor  tissues.  The  resulting  antiserum  in  conjunction  with  normal 
serum produced  cytotoxicity with  established  human  tissue  culture  lines  of 
malignant origin or with malignant characteristics but was without effect on 
freshly established lines of human cells or on human or sheep erythrocytes. On 
the other hand, in the present investigation primary isolates of normal human 
amnion cells were used both as the source of antigen for antiserum production 
and as the test cell in immune cytotoxicity. (/7) Bj6rklund performed his experi- 
ments with horse antibody while those reported here employed rabbit antibody. 
Antibodies produced in the horse are known to have very poor complement- 
fixing activity while rabbit antibodies are usually highly active in this property 
(19).  It  is possible,  therefore, that  a  system not  requiring  complement was 
preferentially selected in BjSrklund's experiments by the use of horse antibody. 
Parallel experiments with rabbit antibody would be of great interest. 
These differences have been elaborated primarily as a means of emphasizing 
the  limitations  of  generalizations  about  immune  cytotoxicity.  Apparently 
several systems exist for the killing of host cells by immunologic or serologic 
mechanisms and the particular system selected experimentally may well depend 
on the nature of the cell,  the antibody,  and the normal serum employed. In 
our  own  experiments,  cytotoxicity with  primary  isolates  of  normal  human 
amnion cells depended upon the presence of rabbit antibody, the components 
of human complement, and calcium and magnesium ions. It would be predicted 
that these requirements would apply to many other normal cells and comple- 
ment-fixing antibodies  but  not  necessarily to  systems  with  different charac- 
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The concept of humoral cytotoxins apparently unrelated to the presence of 
specific antibody has existed for many years  (2).  In  this connection, it is of 
interest that Lumsden (39), Bolande and Todd (41), and others (13,  40) have 
found  that  normal  serums,  in  the  absence  of demonstrable  antibody,  have 
cytotoxic activity for  certain  established  cell lines in  tissue  culture. On the 
other  hand,  numerous  investigators  have  demonstrated  the  necessity  for 
specific cytotoxic antibodies  (2-14,  36-40).  Ross  has  delineated  five criteria 
for  establishing  the  participation  of specific anticeUular  antibodies  in  cyto- 
toxicity (43). All of these criteria have been fulfilled in the present investigation. 
(a) The preimmunization and postimmunization sera from 31 individual rabbits 
were tested for the presence of anti-amnion antibodies. In none of the preim- 
munization sera were they found whereas all the postimmunization sera con- 
tained  them  in  varying amounts.  (b)  Preliminary control  experiments  with 
heated antiserum and heated human serum failed to demonstrate cytotoxicity. 
(c)  In no instance was either heated antiserum or complement alone able to 
elicit  cytotoxicity. (d)  The cytotoxic factor could be adsorbed  from postim- 
munization serum by human amnion cells but not by human AB erythrocytes 
or sources of Forssman antigen.  (e) Progressive increase of the titer of cytotoxic 
antibodies  with  continued  immunization  of  individual  rabbits  was  demon- 
strable, although these data have not been presented. If a rabbit was able to 
produce potent antiserum (CF titer of 1/192 or greater in these experiments), 
it acquired this level gradually and with repeated stimulation.  Some rabbits 
were never able to produce a potent antiserum and at least 18 of them exhibited 
a  decrease in  titer following antigenic  stimulation  which  was  continued for 
over a year. 
The conclusions drawn  from the data presented have been based  in most 
instances on two  independent  criteria of cytotoxicity: metabolism-inhibition 
and uptake of trypan blue. Both of these techniques have been widely used as 
indicators of cell viability under well defined experimental conditions (2, 5, 6, 
8,  14-16,  44-46).  Uptake  of trypan blue  proved  to  be  a  rapid,  convenient, 
and  reproducible  procedure for measuring  the  cytotoxic activity of normal 
human serum on human amnion cells sensitized with rabbit antibody. A small 
percentage of cells used as controls was always stained (1 to 19 per cent, average 
8 per cent) and could be attributed to the trypsinization procedure, storage, 
and manipulations  involved in preparation of the sensitized cells.  The effect 
of whole human serum, at the level of either 1 or 2 CIH100 units, resulted in at 
least 75 per cent staining and usually 90 to 100 per cent of sensitized amnion 
cells.  There was therefore a clear difference between uptake of trypan blue by 
amnion cells in control and experimental series in each protocol. This technique 
permitted  the  study  of  separate  reaction  stages  and  the  functional  role  of 
C'l-esterase  in  immune  cytotoxicity.  The  results  of  this  investigation  are 
presented in the following paper (16). 1104  IMMUNE CELLULAR INJURY. I 
SUMMARY 
A  model system for the investigation  of immune cellular  injury in primary 
isolates  of a fixed-tissue  cell  of  human origin  has been described,  using metabo- 
lism-inhibition  and uptake of trypan blue as independent criteria  of cytoxicity. 
Cytotoxic effects  on human amnion cells  were produced by the combination of 
specific rabbit antibody and factors in normal  human  serum  which  were 
indistinguishable  from the components of hemolytic complement and calcium 
and magnesium ions.  The data have been discussed in relation  to the apparent 
multiplicity of serologic  systems which can effect  cellular  injury. The nature 
of the cell  and the source of antibody or normal serum constituents have been 
emphasized as factors which may  influence the experimental selection of a 
given humoral mechanism. 
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